KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $269.0 million.

  • Cme's Tax Provisions rose 185.54% to $269.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1013.2%. This contributed to the annual value of $1.0 billion for FY2024, which is 951.05% up from last year.
  • Cme's Tax Provisions amounted to $269.0 million in Q3 2025, which was up 185.54% from $305.2 million recorded in Q2 2025.
  • Over the past 5 years, Cme's Tax Provisions peaked at $305.2 million during Q2 2025, and registered a low of $169.6 million during Q3 2021.
  • For the 5-year period, Cme's Tax Provisions averaged around $228.5 million, with its median value being $222.0 million (2024).
  • The largest annual percentage gain for Cme's Tax Provisions in the last 5 years was 5798.55% (2021), contrasted with its biggest fall of 2022.47% (2021).
  • Cme's Tax Provisions (Quarter) stood at $174.1 million in 2021, then increased by 8.79% to $189.4 million in 2022, then rose by 1.06% to $191.4 million in 2023, then grew by 15.99% to $222.0 million in 2024, then increased by 21.17% to $269.0 million in 2025.
  • Its Tax Provisions stands at $269.0 million for Q3 2025, versus $305.2 million for Q2 2025 and $288.6 million for Q1 2025.